Emergency Valve Intervention in Decompensated Severe Aortic Stenosis: Urgent Transcatheter Aortic Valve Implantation and Balloon Valvuloplasty

Severe aortic stenosis frequently first comes to medical attention, or abruptly worsens, as acute decompensation: pulmonary oedema, refractory heart failure or cardiogenic shock.Many of these patients are already known to have significant stenosis and are waiting for valve replacement.Medical therapy has little to offer in this setting, and the two practical interventional options are urgent or emergent transcatheter aortic valve implantation (TAVI) and balloon aortic valvuloplasty (BAV), used either as a definitive rescue or as a bridge to later valve replacement.This narrative review summarises the observational evidence on both strategies.Across registries and single-centre series, urgent TAVI accounts for roughly 5-10% of TAVI procedures and achieves device success comparable to elective TAVI.However, it is associated with more acute kidney injury and higher early mortality, although the size of the mortality difference varies between studies and several did not find a significant difference after adjustment; the excess risk appears to be concentrated early after the procedure.Within the urgent population, shorter time from admission to TAVI has been associated with better mid-term outcomes in observational studies.BAV can stabilise patients rapidly and remains useful when TAVI is unavailable or the patient is too unstable, but it is a temporary measure that the 2025 European guidelines reserve for carefully selected patients, and comparative series report higher mortality with a BAV-first strategy than with direct TAVI.All of these comparisons are confounded by patient selection.The available data support direct TAVI where feasible, BAV as a rescue or bridge, attention to renal protection and close follow-up after discharge.Above all, they support faster elective pathways that prevent decompensation in the first place.Randomised data and standardised definitions are needed.

Authors

Institutions

Publication Details

Journal
Cureus
Published
2026-11-13
DOI
https://doi.org/10.7759/cureus.119622
Primary Topic
Cardiac Valve Diseases and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Emergency Valve Intervention in Decompensated Severe Aortic Stenosis: Urgent Transcatheter Aortic Valve Implantation and Balloon Valvuloplasty

Mhd Anas Murad, Ahmed Abdullah, Mohamed Elbouhi, Mohamed Elgamal et al.
1 links
Cureus
Cardiac Valve Diseases and Treatments
article

Emergency Valve Intervention in Decompensated Severe Aortic Stenosis: Urgent Transcatheter Aortic Valve Implantation and Balloon Valvuloplasty

Mhd Anas Murad, Ahmed Abdullah, Mohamed Elbouhi, Mohamed Elgamal, Mohamed Abdelazim, Abdulrahman Mahmoud Abdelhady Bayomi, Hamza Murad, Mohammed R Mohsen
article en

Abstract

Severe aortic stenosis frequently first comes to medical attention, or abruptly worsens, as acute decompensation: pulmonary oedema, refractory heart failure or cardiogenic shock.Many of these patients are already known to have significant stenosis and are waiting for valve replacement.Medical therapy has little to offer in this setting, and the two practical interventional options are urgent or emergent transcatheter aortic valve implantation (TAVI) and balloon aortic valvuloplasty (BAV), used either as a definitive rescue or as a bridge to later valve replacement.This narrative review summarises the observational evidence on both strategies.Across registries and single-centre series, urgent TAVI accounts for roughly 5-10% of TAVI procedures and achieves device success comparable to elective TAVI.However, it is associated with more acute kidney injury and higher early mortality, although the size of the mortality difference varies between studies and several did not find a significant difference after adjustment; the excess risk appears to be concentrated early after the procedure.Within the urgent population, shorter time from admission to TAVI has been associated with better mid-term outcomes in observational studies.BAV can stabilise patients rapidly and remains useful when TAVI is unavailable or the patient is too unstable, but it is a temporary measure that the 2025 European guidelines reserve for carefully selected patients, and comparative series report higher mortality with a BAV-first strategy than with direct TAVI.All of these comparisons are confounded by patient selection.The available data support direct TAVI where feasible, BAV as a rescue or bridge, attention to renal protection and close follow-up after discharge.Above all, they support faster elective pathways that prevent decompensation in the first place.Randomised data and standardised definitions are needed.

Cureus
Al-Azhar University (EG), Royal Cornwall Hospital Trust (GB), Royal Cornwall Hospital (GB), Al-Azhar University (ID)
Good health and well-being
Cardiac Valve Diseases and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon